唾液胃蛋白酶对胃食管反流病诊断的研究进展

doi:10.3969/j.issn.1004-583X.2022.06.016

摘要/Abstract

摘要：

胃食管反流病(gastroesophageal reflux disease, GERD)是一种临床常见病,患病率在不同国家或地区差异较大, 我国 GERD 患病率有逐年上升趋势。目前GERD的诊断方法主要包括质子泵抑制剂(proton pump inhibitors, PPIs)诊断性治疗、调查问卷法和24 h食管pH-阻抗监测(24 hours pH and multichannel intraluminal impedancemetry, 24hpH-MII)及胃镜检查等。目前GERD的金标准是24hpH-MII,但其具有费用高、有创性、耐受性差等缺点。所以需要一种非侵入性和经济有效的诊断方法。近年来唾液胃蛋白酶检测在GERD诊断中应用的研究备受关注,本文就唾液胃蛋白酶检测在GERD的诊断价值及在临床应用前景等现状作一综述。

中图分类号:

R573.9

赵爽, 张月寒, 胡宵月, 于亭亭, 苏园园, 郑吉敏. 唾液胃蛋白酶对胃食管反流病诊断的研究进展[J]. 临床荟萃, 2022, 37(6): 560-563.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2022.06.016

https://huicui.hebmu.edu.cn/CN/Y2022/V37/I6/560

参考文献 34

[1]	中国医疗保健国际交流促进会胃食管反流多学科分会. 中国胃食管反流病多学科诊疗共识[J]. 中国医学前沿杂志:电子版, 2019, 11(9):30-56.
[2]	Guo Z, Wu Y, Chen J, et al. The role of salivary pepsin in the diagnosis of gastroesophageal reflux disease (GERD) evaluated using high-resolution manometry and 24-hour multichannel intraluminal impedance-ph monitoring[J]. Med Sci Monit, 2020, 26: e927381.
[3]	邹亚竹. 胃蛋白酶与反流相关性疾病研究进展[J]. 检验医学与临床, 2018, 15(22):3472-3475.
[4]	Klimara M, Johnston N, Samuels T, et al. Correlation of salivary and nasal lavage pepsin with MII-pH testing[J]. Laryngoscope, 2020, 130(4): 961-966. doi: 10.1002/lary.28182
[5]	Wang J, Zhao Y, Ren J, et al. Pepsin in saliva as a diagnostic biomarker in laryngopharyngeal reflux: a meta-analysis[J]. Eur Arch Otorhinolaryngol, 2018, 275(3):671-678. doi: 10.1007/s00405-017-4845-8 URL
[6]	Akbulut S, Aydinli FE, Kuscu O, et al. Reliability and validity of the turkish reflux symptom index[J]. J Voice, 2020, 34(6): 965 e23-965 e28.
[7]	Vance D, Alnouri G, Shah P, et al. The validity and reliability of the reflux finding score[J]. J Voice, 2020 :S0892- 1997(20)30421-5.
[8]	Wang Y, Lang X, Wu D, et al. Salivary pepsin as an intrinsic marker for diagnosis of sub-types of gastroesophageal reflux disease and gastroesophageal reflux disease-related disorders[J]. J Neurogastroenterol Motil, 2020, 26(1): 74-84. doi: 10.5056/jnm19032 URL
[9]	Strugala V, Woodcock AD, Dettmar PW, et al. Detection of pepsin in sputum: a rapid and objective measure of airways reflux[J]. Eur Respir J, 2016, 47(1): 339-341. doi: 10.1183/13993003.00827-2015 pmid: 26541528
[10]	Wang C, Wang C, Lien H, et al. Saliva pepsin detection and proton pump inhibitor response in suspected laryngopharyngeal reflux[J]. Laryngoscope, 2019, 129(3): 709-714. doi: 10.1002/lary.27502 URL
[11]	Du X, Wang F, Hu Z, et al. The diagnostic value of pepsin detection in saliva for gastro-esophageal reflux disease: a preliminary study from China[J]. BMC Gastroenterol, 2017, 17(1): 107. doi: 10.1186/s12876-017-0667-9 URL
[12]	Hayat J, Gabieta-Somnez S, Yazaki E, et al. Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease[J]. Gut, 2015, 64(3): 373-80. doi: 10.1136/gutjnl-2014-307049 URL
[13]	郎秀琼, 何雨芩, 杨均, 等. 唾液胃蛋白酶在不同亚型胃食管反流病中的诊断价值[J]. 中华消化杂志, 2017, 37(7):473-475.
[14]	Kim T, Lee K, Yeo M, et al. Pepsin detection in the sputum/saliva for the diagnosis of gastroesophageal reflux disease in patients with clinically suspected atypical gastroesophageal reflux disease symptoms[J]. Digestion, 2008, 77(3-4):201-206.
[15]	Weitzendorfer M, Antoniou S, Schredl P, et al. Pepsin and oropharyngeal pH monitoring to diagnose patients with laryngopharyngeal reflux[J]. Laryngoscope, 2020, 130(7): 1780-1786. doi: 10.1002/lary.28320
[16]	Na S, Kwon O, Lee Y, et al. Optimal timing of saliva collection to detect pepsin in patients with laryngopharyngeal reflux[J]. Laryngoscope, 2016, 126(12): 2770-2773. doi: 10.1002/lary.26018 URL
[17]	刘泽阳, 许洪波, 郭伟, 等. 胃蛋白酶在咽喉反流与喉癌中的临床意义及研究进展[J]. 临床耳鼻咽喉头颈外科杂志, 2018, 32(7):559-562.
[18]	Zhang M, Chia C, Stanley C, et al. Diagnostic utility of salivary pepsin as compared with 24-hour dual ph/impedance probe in laryngopharyngeal reflux[J]. Otolaryngol Head Neck Surg, 2021, 164(2):375-380. doi: 10.1177/0194599820951183 URL
[19]	Barona-Lleo L, Barona-De Guzman R, Krstulovic C. The Diagnostic Usefullness of the Salivary Pepsin Test in Symptomatic Laryngopharyngeal Reflux[J]. J Voice, 2019, 33(6): 923-928. doi: S0892-1997(18)30081-X pmid: 30314932
[20]	Lechien J, Bobin F, Dapri G, et al. Hypopharyngeal-Esophageal Impedance-pH Monitoring Profiles of Laryngopharyngeal Reflux Patients[J]. Laryngoscope, 2021, 131(2): 268-276. doi: 10.1002/lary.28736 URL
[21]	Yin C, Zhang S, Zhong J, et al. Pepsin and Laryngeal and Hypopharyngeal Carcinomas[J]. Clin Exp Otorhinolaryngol, 2021, 14(2): 159-168. doi: 10.21053/ceo.2020.00465 URL
[22]	Vaezi M, Sifrim D. Assessing old and new diagnostic tests for gastroesophageal reflux disease[J]. Gastroenterology, 2018, 154(2): 289-301. doi: 10.1053/j.gastro.2017.07.040 URL
[23]	Dy F, Amirault J, Mitchell P, et al. Salivary pepsin lacks sensitivity as a diagnostic tool to evaluate extraesophageal reflux disease[J]. J Pediatr, 2016, 177: 53-58. doi: 10.1016/j.jpeds.2016.06.033 URL
[24]	Zeleník K, Hránková V, Vrtková A, et al. Diagnostic value of the peptest in detecting laryngopharyngeal reflux[J]. J Clin Med, 2021, 10(13):2996. doi: 10.3390/jcm10132996 URL
[25]	Guo Z, Jiang J, Wu H, et al. Salivary peptest for laryngopharyngeal reflux and gastroesophageal reflux disease: A systemic review and meta-analysis[J]. Medicine (Baltimore), 2021, 100(32): e26756. doi: 10.1097/MD.0000000000026756 URL
[26]	Lechien J, Bobin F, Muls V, et al. Saliva pepsin concentration of laryngopharyngeal reflux patients is influenced by meals consumed before the samples[J]. Laryngoscope, 2021, 131(2): 350-359. doi: 10.1002/lary.28756 URL
[27]	Jung A, Kwon O, Park J, et al. Association between pepsin in the saliva and the subjective symptoms in patients with laryngopharyngeal reflux[J]. J Voice, 2019, 33(2): 150-154. doi: S0892-1997(17)30298-9 pmid: 29174850
[28]	Lechien J, Bobin F, Muls V, et al. Patients with acid, high-fat and low-protein diet have higher laryngopharyngeal reflux episodes at the impedance-pH monitoring[J]. Eur Arch Otorhinolaryngol, 2020, 277(2): 511-520. doi: 10.1007/s00405-019-05711-2 pmid: 31679054
[29]	Bobin F, Journe F, Lechien J. Saliva pepsin level of laryngopharyngeal reflux patients is not correlated with reflux episodes[J]. Laryngoscope, 2020, 130(5): 1278-1281. doi: 10.1002/lary.28260
[30]	Race C, Chowdry J, Russell J, et al. Studies of salivary pepsin in patients with gastro-oesophageal reflux disease[J]. Aliment Pharmacol Ther, 2019, 49(9): 1173-1180. doi: 10.1111/apt.15138 URL
[31]	Katzka D, Pandolfino J, Kahrilas P. Phenotypes of gastroesophageal reflux disease: Where rome, lyon, and montreal meet[J]. Clin Gastroenterol Hepatol, 2020, 18(4): 767-776. doi: 10.1016/j.cgh.2019.07.015 URL
[32]	Woodland P, Singendonk M, Ooi J, et al. Measurement of salivary pepsin to detect gastroesophageal reflux disease is not ready for clinical application[J]. Clin Gastroenterol Hepatol, 2019, 17(3): 563-565. doi: 10.1016/j.cgh.2018.05.016 URL
[33]	Fortunato J, D'agostino R, Lively M. Pepsin in saliva as a biomarker for oropharyngeal reflux compared with 24-hour esophageal impedance/pH monitoring in pediatric patients[J]. Neurogastroenterol Motil, 2017, 29(2).
[34]	Yadlapati R, Adkins C, Jaiyeola D, et al. Abilities of oropharyngeal pH tests and salivary pepsin analysis to discriminate between asymptomatic volunteers and subjects with symptoms of laryngeal irritation[J]. Clin Gastroenterol Hepatol, 2016, 14(4): 535-542.e2. doi: 10.1016/j.cgh.2015.11.017 URL

唾液胃蛋白酶对胃食管反流病诊断的研究进展

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 34

相关文章 15

编辑推荐

Metrics

本文评价

[1]	郑志璇, 平芬, 李萍, 吴国飘. 阻塞性睡眠呼吸暂停低通气综合征与支气管哮喘关系的研究进展[J]. 临床荟萃, 2023, 38(10): 940-943.
[2]	鞠岩, 郭鹏, 吴伯韬, 刘新宇. 唾液血液尿酸比与糖尿病周围神经病变的相关性[J]. 临床荟萃, 2023, 38(1): 37-41.
[3]	晋颖, 汪湃, 冯世兵. 幽门螺杆菌及胃蛋白酶原、胃泌素17水平在胃癌前病变诊断中的应用价值[J]. 临床荟萃, 2021, 36(3): 233-237.
[4]	吴杰，赖跃兴，吴梅，于海滨，杨静，袁海朋. 健康教育加辅助措施提高上消化道内镜检查黏膜清晰度的临床观察[J]. 临床荟萃, 2020, 35(5): 434-437.
[5]	应笑，吕宾. 胃蛋白酶原和胃泌素17在诊断萎缩性胃炎中的价值[J]. 临床荟萃, 2019, 34(5): 403-406.
[6]	朱春平, 刘肖肖，李兆申. 胃泌素与胃食管反流病的相关性研究进展[J]. 临床荟萃, 2018, 33(6): 541-544.
[7]	韩英. 非心源性胸痛治疗的现状及进展[J]. 临床荟萃, 2017, 32(1): 50-53.
[8]	丁钰，闫秀娥. 嗜酸性食管炎与胃食管反流病关系[J]. 临床荟萃, 2017, 32(1): 42-45.
[9]	苏少慧. 胃食管反流病的心身因素及处置[J]. 临床荟萃, 2017, 32(1): 37-41.
[10]	刘改芳. 幽门螺杆菌与胃食管反流病[J]. 临床荟萃, 2017, 32(1): 33-36.
[11]	吴继敏. 胃食管反流病外科治疗相关问题探讨[J]. 临床荟萃, 2017, 32(1): 28-32.
[12]	江文俊，周丽雅. 胃食管反流病的内镜治疗[J]. 临床荟萃, 2017, 32(1): 22-27,32.
[13]	韩菲，张晓岚. 胃食管反流病的药物治疗[J]. 临床荟萃, 2017, 32(1): 17-21.
[14]	牛巍巍，尹凤荣. 胃食管反流病诊断技术进展[J]. 临床荟萃, 2017, 32(1): 13-16,21.
[15]	白研1，白文元2. 难治性胃食管反流病的识别与治疗进展[J]. 临床荟萃, 2017, 32(1): 9-12.